Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

Click for more information

0.00%

4.1¢ incannex healthcare limited

Nasdaq listing, 1 Year on., page-74

First 74 Last

Share
Profile

Follow
SmellyFeet

17 Posts.

10

15/02/23

09:55

Post #: 66254458
Share

Originally posted by MickeyMantle536: ↑

@Lurker99

Regrettably I missed your post until this evening.

You’ve asked a fair question, although from my perspective it’s been more than adequately addressed with the public announcements and Joel’s interview.

The 35c entitlement offer was announced on 18 March 2022 when the SP was 69.5c. We all had a very attractive opportunity to buy stock at a 49.6% discount to the SP, plus a free option that was 43.8% out of the money.

Fast forward 8 months to 5 December 2022 and the SP is now 23c and the small cap environment is diabolical, particularly health sciences. I think we can agree that market conditions changed significantly during that 8 month period.

Now the Company places A$13 million to a strategic consortium at 20.5c with the SP at 23c. This is a 10.9% discount with an option that was 23.9% out of the money at the time.

Sure, the terms of these two deals are very different. But they also occurred 8 months apart under entirely different circumstances and market conditions.

Playing the devils advocate for a moment. Let’s imagine we’re trading at $1.50 in another 8 months time. Does the company raise capital at 35c with a $1.00 option simply because that’s “fair” based on the CR we participated in? Of course not, that would be ridiculous, uncommercial.

Perhaps you can suggest how the “frame of reference” based on the “company's central ethos” of “investor value” is applied in these scenarios. It can’t be in my opinion, nor should it.

We hold the same position that “track record” (which Joel and the board hold in Spades) is the driver for long term value. The strategic nature of this recent investment is not public information and until it is then investors place their trust in the capability of the board.

No-one is entitled to understand more than what’s been publicly disclosed and frankly if the SP was 40c then no-one would even care IMO. The sentiment on HC is predicated on the SP.

Unfortunately the company doesn’t operate in an economic vacuum and market conditions impact the price regardless of its prospects. I actually can’t recall a greater disconnect between the opportunity and the SP.

But as you’d expect, the noise in this environment will be dominated by the uninformed and emotionally charged punter, just as it is in many aspects of life ATM.

Expand

@MickeyMantle536 - when you say that no one is entitled to understand more than what’s been publicly disclosed -does this include you?

And I agree that if the share price was 40c then no-one would even care. But it's not. So surely even you, the company's biggest fan boy, must understand why shareholders are asking unanswered questions about the CR when the share price has fallen from 23.5 cents to 15.5 cents since it was done. Particularly given the messaging from the Board leaving up to the raise.

For the record, I've been an investor for many years and still have confidence in the Board and the prospects of the Company, but I also believe that the CR and the messaging around it has been handled extremely poorly.

IHL Price at posting: 15.5¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

LTP

'Nasal spray viagra' company LTR Pharma jumps 8% on second prescription under TGA access scheme

From the Floor with Kim Beazley at Diggers and Dealers 2024

CDE

Codeifai's QR code product integrated by pre-US-IPO darling Canva – but also announces $0.6M placement

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Revolutionary inverter technology leads the clean energy charge

There are more pages in this discussion • 21 more messages in this thread...

First 74 Last

Add IHL (ASX) to my watchlist